| Description |
1 online resource (xi, 219 pages) : illustrations |
| Contents |
LUPUS: SYMPTOMS, TREATMENT AND POTENTIAL COMPLICATIONS; LUPUS: SYMPTOMS, TREATMENT AND POTENTIAL COMPLICATIONS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter I: Lupus Erythematosus: A Comprehensive Review; Abstract; Abbreviations; Defining Lupus; Lupus Incidence and Prevalence; Causes of Lupus; Diagnosing Lupus; Autoantibodies in Lupus; Lupus Blood Tests; Urine Testing; Other Tests; Pregnancy and Contraception for Women with Lupus; Current Research in Lupus; Genetics in Lupus; Biomarkers; The Disease Process; Lupus and the Skin, Hair and Mucosae |
|
Lupus and the SunLupus and the Musculoskeletal System; Podiatric Care in Lupus; Lupus and the Mucosae; Mixed Connective Tissue Disease, or Overlap Syndrome; Differential Diagnoses of Lupus; Coping with Lupus among Family and Friends; Treatment; NSAIDs; Antimalarials; Corticosteroids; Immunosuppressives; BLyS-Specific Inhibitors; Other Lupus Therapies; Alternative and Complementary Therapies; References; Chapter II: Autoantibody-Producing B Cellsand B Cell Therapy in Systemic Lupus Erythematosus -- Possible New Targets of Novel Subsets of RP105-NegativeB Cells; Abstract; Introduction |
|
Section 1. B Cell Biology in SLESection 2. Therapies of Targeting B Cells in SLE; Conclusion; Reference; Chapter III: Neuropsychiatric Manifestations in Systemic Lupus Erythematosus; Abstract; Introduction; Classification Criteria; NPSLE Epidemiology; Clinical Relevance; Risk Factors for NPSLE; Pathophysiology; Diagnosis; Clinical and Laboratory Investigation; Therapeutic Strategies in NPSLE; Conclusion; Acknowledgments; References; Chapter IV: Treatment in Systemic Lupus Erythematosus; Abstract; Introduction; Conventional Therapies; B-Cell Targeting |
|
T-Cell Targeting and Co-Stimulatory BlockadeAnticytokines Therapy; Complement Inhibition; Conclusion; Acknowledgments; References; Chapter V: Hematologic Manifestations of Systemic Lupus Erythematosus; Anemia; Leukopenia; Lymphopenia; Neutropenia; Thrombocytopenia; Bone Marrow as a Target Organ in SLE; Hematological Manifestations, SLE Subsets and Prognosis; References; Chapter VI: Interleukin-21 in Systemic Lupus Erythematosus: Pathogenic Relevance and Therapeutic Applications; Abstract; Introduction: Overview on Systemic Lupus Erythematosus; Multiple Roles for B Cells in SLE |
|
IL-21 Is aCritical Regulator of B Cell ResponsesIL-21 and SLE; Treatment of Spontaneous Lupus Mice Using Agents Able to Block IL-21/IL-21R Signaling; Conclusion; References; Chapter VII: Metabolic Syndrome and Inflammatory Cytokines in Systemic Lupus Erythematosus; Abstract; Introduction; CVD in SLE; Traditional Risk Factors; Non-Traditional Risk Factors; CVD Features and Cytokines Involved on SLE; Relationship between SLE Treatment in Patients with MetS; What Is the Best Treatment to MetS in SLE Patients?; Conclusion and Perspective Future; Acknowledgments; References |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Print version record |
| Subject |
Systemic lupus erythematosus.
|
|
Lupus Erythematosus, Systemic
|
|
HEALTH & FITNESS -- Diseases -- Musculoskeletal.
|
|
MEDICAL -- Orthopedics.
|
|
MEDICAL -- Rheumatology.
|
|
Systemic lupus erythematosus
|
| Form |
Electronic book
|
| Author |
Marquez, Thiago Devesa, editor
|
|
Neto, Davi Urgeiro, editor
|
| LC no. |
2012931745 |
| ISBN |
9781620810989 |
|
1620810980 |
|
